Electron Activated Dissociation Technique for Middle-Down Mass Spectrometric Analysis of Disulphide Bonds and Free Thiols: Application in Characterising Monoclonal Antibody Biotherapeutic Fragments

Authors:

Abstract
Disulphide bonds contribute to the conformational structure of monoclonal antibodies (mAbs) and are therefore vital for their stability, biological function and safety. However, the biopharmaceutical manufacturing process can influence these bonds, potentially leading to the formation of free thiols, scrambled configurations, or degradation products, which may negatively impact quality and safety. Current analytical strategies for characterising disulphide bonds and free thiols in mAbs are predominantly based on labelled and label-free bottom-up mass spectrometry approaches. However, these methods are often time-consuming and may generate unwanted artefacts such as disulphide bond scrambled products. As a result, middle-down and top-down mass spectrometry methods are being explored as alternative approaches. However, their broader application remains limited by challenges in achieving sufficient MS/MS fragmentation for reliable characterisation of protein modifications and disulphide linkages. In this study, we evaluated an electron-activated dissociation (EAD) on the Sciex ZenoTOF 7600+ system for middle-down characterisation of intra- and interchain DSB and free thiols in mAbs. The EAD fragmentation generated diagnostic fragment ion patterns that can confirm intra-chain disulphide linkages on the subunits. This approach was applied to assess domain-specific free thiol on the NISTmAb Fc/2 subunit, as well as disulphide-scrambled products generated from mild reduction. Additionally, the method was effective in characterising fragments from antibody degradation. Overall, this EAD-based approach provides a rapid alternative for antibody product characterisation across different stages of the production process.